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The biotech industry has seen an explosion in the development of therapeutic antibodies in the last decade. The 
advantages of antibodies as therapeutics – namely their high affinity, specificity, potency, stability, 
manufacturability and low toxicity – are compelling. Nevertheless, there are many challenges associated with 
antibody discovery and development that require key technical advances to improve the rational and reliable 
generation of potent antibody therapeutics. We have made three key discoveries that address some of these 
fundamental challenges related to the design and selection of antibodies with high affinity, specificity, stability 
and solubility. First, we find that the accumulation of affinity-enhancing mutations in the 
complementaritydetermining regions (CDRs) during affinity maturation is often a destabilizing process. 
Surprisingly, mutations that enhance antibody binding affinity are commonly destabilizing. Second, we have 
developed novel yeast surface display methods for co-evolving antibody affinity and stability to address the 
general problem of antibody destabilization during affinity maturation. Our approach simultaneously evaluates 
antibody binding to both antigen and a conformational ligand that acts as a folding sensor to rapidly identify sets 
of mutations that promote both high antibody affinity and stability. This methodology has enabled us to identify 
novel compensatory mutations that offset the destabilizing effects of affinity-enhancing mutations and lead to 
affinitymaturated antibodies with high thermodynamic stability. Interestingly, our directed evolution method 
appears to mimic some aspects of natural antibody evolution, as natural antibodies also accumulate similar 
types of compensatory mutations to maintain thermodynamic stability during in vivo affinity maturation. Third, we 
have developed novel antibody library design and selection methods for generating antibodies with high 
specificity. It is common for antibody specificity to be compromised during in vitro affinity maturation. We have 
developed innovative methods for designing antibody libraries based on natural antibody diversity to 
simultaneously sample residues at many sites in the CDRs and framework regions that are most likely to 
promote high specificity. By coupling these nature-inspired antibody libraries with novel positive and negative 
selection methods, we have isolated antibodies with specificities that rival those of natural antibodies and which 
are much higher than typical antibodies identified using in vitro selection methods. Interestingly, we find that 
antibodies with improved specificity also possess excellent biophysical properties, including high solubility and 
stability. We are currently using computational methods to understand how rare antibody variants are able to 
maintain high specificity and stability during affinity maturation. Our long-term goal is to develop systematic and 
robust design methods to rapidly generate and optimize antibodies for use in a range of diagnostic and 
therapeutic applications.   
  
